A North America investor event that was already on Reckitt's calendar has taken on extra weight after Lysol supply problems pushed the region into decline and contributed to a guidance cut that sent the FTSE 100 group's shares down 4.9%.
A date that has gained significance
Investor events are usually planned long in advance, and their importance can shift with circumstances. Reckitt's (LSE:RKT) North America event, scheduled for Thursday 19 November 2026 at its New Jersey headquarters, is a case in point. When the company published its third-quarter trading update on Tuesday 27 October 2026, North America emerged as the weakest of its three regions, and the gathering in New Jersey suddenly looked less like a routine showcase and more like an opportunity to rebuild confidence.
The market's verdict on the update was harsh. Reckitt cut its full-year 2026 Core like-for-like revenue growth guidance to 3.5%–4.5% from 4%–5%, and its shares closed 4.9% lower at 5,218p. The FTSE 100 as a whole fell 80.79 points, or 0.8%, to 10,686.54, with Reckitt among its biggest decliners.
What went wrong in North America
North America revenue fell 1.3% on a like-for-like basis to £649m in the third quarter. The main cause was temporary manufacturing capacity constraints affecting Lysol, the group's disinfectant brand. Reckitt said improvements were under way and that it expects a recovery in the fourth quarter.
The region's weakness fed into the group numbers. Core Reckitt revenue was £2.69bn, up 3.3% like for like, against the 3.6% the market had expected. Volumes rose only 0.1%, with price and mix providing 3.2% of growth. Elsewhere, Reckitt also cited slower growth in China's vitamins, minerals and supplements category and tougher competition for Finish in dishwashing.
North America is far from the only region that matters – Emerging Markets grew 8.0% to £1.17bn and Europe rose 0.8% to £867m – but it is the one where the problem is most clearly identified and, according to the company, most clearly fixable. That makes it the natural focus of a dedicated investor event.
Why the event could matter
Reckitt has already laid some groundwork. In September 2026 it announced a North America investment programme of up to US$600m, and the trading update described improvements to manufacturing capacity as under way. An investor day held at the regional headquarters would typically give management a platform to explain such plans in more depth than a quarterly statement allows.
Events of this kind also matter because of their format. A quarterly update is a written statement followed by a short call; an investor day usually involves presentations from regional and operational managers, site visits or product demonstrations, and extended question-and-answer sessions. That gives investors a chance to test assumptions directly with the people running the business. After a guidance cut, such access can either reassure the market or deepen its doubts, depending on how convincing the explanations prove.
Without guessing at what Reckitt will announce, it is possible to outline the kinds of questions investors are likely to bring. First, timing: how quickly Lysol supply is returning to normal, and whether the expected fourth-quarter recovery is on track. Second, resilience: how the investment programme is designed to reduce the risk of similar constraints recurring. Third, market position: whether retailers and consumers have stayed loyal during the shortage, or whether competitors have gained ground that will need to be won back.
Investors may also look for context on how North America fits with the group's broader targets. Reckitt kept its adjusted operating margin guidance unchanged at 24.9%–25.6% for Core Reckitt and Mead Johnson combined, and maintained its medium-term ambition of 4%–5% like-for-like growth. Because North America shrank in the third quarter, a credible return to growth there is arguably one of the conditions for reaching the upper part of that medium-term range.
If a region generating £649m a quarter moved from a 1.3% decline to 2% growth, the swing would be 3.3 percentage points, or about £21m of quarterly revenue (£649m × 3.3% ≈ £21.4m). That is close to 0.8% of Core Reckitt's £2.69bn quarterly revenue (£21.4m ÷ £2,690m ≈ 0.8%). The 2% growth figure is purely hypothetical and is not a company forecast.
The event will take place against a backdrop of other moving parts. Reckitt's £500m buyback began on 5 August 2026, and about £90m had been completed by 23 October. The sale of Russia Hygiene is expected to complete in the second half of 2026. Group revenue of £3.36bn was down 6.9% on a reported basis, largely because the Essential Home disposal completed on 31 December 2025, reflecting a more focused portfolio.
Chief executive Kris Licht sought to strike a positive note, saying "We enter Q4 with good momentum". The New Jersey event gives management an opportunity to substantiate that view with detail, and investors are likely to compare whatever is said there with the fourth-quarter trading that follows.
On the day of the update, Reckitt was down 4.94% at 5,234p in afternoon trade, close to its final level. The broader market offered little shelter: HSBC fell 5.4% after its results, BP and Shell slipped with weaker oil, and the FTSE 100 lagged European and US markets even as the FTSE 250 gained 0.9%. Chancellor John Healey's first Autumn Budget and the US Federal Reserve decision, both on Wednesday 28 October, added to the caution.
Key dates to watch
- Wednesday 28 October 2026 – UK Autumn Budget and US Federal Reserve rate decision
- Wednesday 28 October 2026 – Unilever Q3 trading statement
- Thursday 29 October 2026 – Haleon Q3 trading statement
- Thursday 5 November 2026 – Bank of England MPC decision
- Thursday 19 November 2026 – Reckitt North America investor event, New Jersey headquarters
The bottom line
Reckitt's 19 November event in New Jersey has become more important because North America is now where the company's most visible problem sits. A 1.3% regional decline, driven by Lysol capacity constraints, contributed to a trimmed growth outlook and a 4.9% share price fall. With a US$600m investment programme announced and a fourth-quarter recovery expected, the event offers management a chance to set out how it intends to restore growth. For FTSE 100 investors, the clarity – or lack of it – provided in New Jersey, alongside actual fourth-quarter trading, is likely to influence how the revised guidance is viewed.
_11_16_2026_14_47_34_233787.jpg)





Please wait processing your request...